Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Invanz (ertapenem, legacy) by Year
Invanz (ertapenem, legacy) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)
Merck Invanz (ertapenem, legacy): -6.0% in FY2021, up 10.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the FY2021 figure comes from
“|| Invanz | 57 | 48 | 53 | 45 | 202 | 64 | 43 | 51 | 53 | 211 | -15 | -15 | -4 | -6”
Source: Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗
Reported in Form 8-K Table 3 / 10-K / 10-Q MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Invanz (ertapenem, legacy) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2021 | Dec 31, 2021 | -6.0% | +10.0 pts | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2020 | Dec 31, 2020 | -16.0% | +28.0 pts | Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗ |
| FY2019 | Dec 31, 2019 | -44.0% | -27.0 pts | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | -17.0% | -24.0 pts | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2017 | Dec 31, 2017 | 7.0% | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Cite this data
StockData. (2026). Merck Invanz (ertapenem, legacy) (%), annual FY2017–FY2021 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-invanz-ww-exfx-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.